The global generic drug market is growing rapidly, driven by biosimilars, rising chronic disease, and demand in emerging economies. Learn how pricing, regulation, and supply chains are shaping the future of affordable medicine.
Tag: biosimilars
11
Dec
Biosimilars are highly similar versions of complex biologic drugs that work just like the original, but often cost less. They’re not generics - they’re scientifically proven alternatives for conditions like arthritis, cancer, and diabetes.
